Kolexia
Chakiba-Brugere Camille
Oncologie médicale
Institut Bergonié
Bordeaux, France
149 Activités
910 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Sarcomes Récidive tumorale locale Tumeurs de l'ovaire Métastase tumorale Tumeurs de l'utérus Carcinome épithélial de l'ovaire Sarcome synovial

Industries

Pfizer
4 collaboration(s)
Dernière en 2023
MSD
2 collaboration(s)
Dernière en 2023
Novartis
2 collaboration(s)
Dernière en 2021
GSK
2 collaboration(s)
Dernière en 2022

Dernières activités

VICTORIA: A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
Essai Clinique (Centre Léon-Bérard)   12 février 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   01 février 2024
Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center.
Acta oncologica (Stockholm, Sweden)   10 novembre 2023
PADA-1: Randomized, Open Label, Multicentric Phase III Trial to Evaluate the Safety and Efficacy of Palbociclib in Combination With HT Driven by ctDNA ESR1 Mutation Monitoring in ER+, HER2-negative Metastatic Breast Cancer Patients
Essai Clinique (Pfizer)   21 septembre 2023
Sein et Radiothérapie - Dr Camille Chakiba, oncologue et Dr Marion Barrault, psychologue
Youtube @ Institut Bergonié   26 juin 2023
One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.
International journal of environmental research and public health   25 mai 2023
ROSALINE: Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast
Essai Clinique (Roche)   14 avril 2023
REGOMUNE: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
Essai Clinique (Merck KGaA)   02 mars 2023
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
Anticancer research   27 janvier 2023
Dépistage du cancer du sein chez la femme âgée
Edimark   30 septembre 2022